Rituximab-treated Rheumatic Patients: B-cell Levels Predict Sero-conversion After COVID-19 Boost or Re-vaccination in Initial Vaccine Non-responders

被引：0
|
作者：
Ammitzboell, Christian [1 ]
Thomsen, Marianne Kragh [2 ]
Andersen, Jakob Bogn [1 ]
Jensen, Jens Magnus Berth [3 ]
Hermansen, Marie-Louise From [1 ]
Johannsen, Anders Dahl [1 ]
Larsen, Mads Lamm [1 ]
Mistegaard, Clara Elbael [1 ]
Mikkelsen, Susan [3 ]
Szabados, Fruzsina [3 ]
Vils, Signe Risbol [1 ]
Erikstrup, Christian [3 ]
Hauge, Ellen-Margrethe [1 ]
Troldborg, Anne [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0762
引用
收藏
页码：1517 / 1520
页数：4
相关论文
共 11 条
  • [1] Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders
    Ammitzboll, Christian
    Kragh Thomsen, Marianne
    Bogh Andersen, Jakob
    Jensen, Jens Magnus Berth
    From Hermansen, Marie-Louise
    Dahl Johannsen, Anders
    Larsen, Mads Lamm
    Mistegaard, Clara Elbaek
    Mikkelsen, Susan
    Szabados, Fruzsina
    Vils, Signe Risbol
    Erikstrup, Christian
    Hauge, Ellen-Margrethe
    Troldborg, Anne
    RHEUMATOLOGY, 2023, 62 (07) : 2544 - 2549
  • [2] RE-VACCINATION COMPARED TO BOOSTER COVID-19 MRNA VACCINATION SIGNIFICANTLY INCREASES THE SEROLOGICAL RESPONSE IN RITUXIMAB-TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES WITHOUT A PRIMARY DETECTABLE SEROLOGICAL COVID-19 VACCINE RESPONSE
    Ammitzboll, C.
    Thomsen, M. K.
    Hermansen, M. L. F.
    Vils, S. R.
    Andersen, J. B.
    Johannesen, A. D.
    Szabados, F.
    Jorgensen, C. M.
    Larsen, M. C. L.
    Erikstrup, C.
    Hauge, E. M.
    Troldborg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 373 - 374
  • [3] Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
    Wagner, Angelika
    Ohradanova-Repic, Anna
    Gebetsberger, Laura
    Tajti, Gabor
    Kundi, Michael
    Stockinger, Hannes
    Wiedermann, Ursula
    Grabmeier-Pfistershammer, Katharina
    IMMUNOLOGY LETTERS, 2022, 250 : 1 - 6
  • [4] B-cell Reconstitution Is Associated with COVID-19 Booster Vaccine Responsiveness in Previously Seronegative Rituximab Treated Rheumatic Disease Patients
    Schultz, Kaitlin
    Jannat-Khah, Deanna
    Spiera, Robert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1550 - 1553
  • [5] Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine
    Nystrom, Jessica
    Cardell, Kristina
    Bjornsdottir, Thora Bjorg
    Fryden, Aril
    Hultgren, Catharina
    Sallberg, Matti
    VACCINE, 2008, 26 (47) : 5967 - 5972
  • [6] B Cell Reconstitution Is Strongly Associated with COVID-19 Vaccine Responsiveness in Rheumatic Disease Patients Treated with Rituximab
    Jinich, Sarah
    Jannat-Khah, Deanna
    Spiera, Robert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3270 - 3273
  • [7] Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
    Bitoun, Samuel
    Avouac, Jerome
    Henry, Julien
    Ghossan, Roba
    Al Tabaa, Omar
    Belkhir, Rakiba
    Nocturne, Gaetane
    Mariaggi, Alice Andree
    Rozenberg, Flore
    Vauloup-Fellous, Christelle
    Mariette, Xavier
    Seror, Raphaele
    RMD OPEN, 2022, 8 (01):
  • [8] B-CELL RECONSTITUTION IS STRONGLY ASSOCIATED WITH A POSITIVE SEROLOGIC RESPONSE TO THE COVID-19 BOOSTER VACCINE IN PREVIOUSLY SEROLOGICALLY UNRESPONSIVE RITUXIMAB TREATED RHEUMATIC DISEASE PATIENTS
    Schultz, K.
    Jannat-Khah, D.
    Spiera, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 929 - 930
  • [9] Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COVID-19 Vaccination
    Zhang-Sun, Jeffrey
    Kirou, Raphael A.
    Kirou, Kyriakos A.
    HSS JOURNAL, 2023, 19 (02) : 180 - 186
  • [10] Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy
    Dulery, Remy
    Lamure, Sylvain
    Delord, Marc
    Di Blasi, Roberta
    Chauchet, Adrien
    Hueso, Thomas
    Rossi, Cedric
    Drenou, Bernard
    Deau Fischer, Benedicte
    Soussain, Carole
    Feugier, Pierre
    Noel, Nicolas
    Choquet, Sylvain
    Bologna, Serge
    Joly, Bertrand
    Philippe, Laure
    Kohn, Milena
    Malak, Sandra
    Fouquet, Guillemette
    Daguindau, Etienne
    Taoufik, Yassine
    Lacombe, Karine
    Cartron, Guillaume
    Thieblemont, Catherine
    Besson, Caroline
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : 934 - 944
12